IP Library Granted Patent US 11,420,159
Granted Patent B2
US 11,420,159 · App. 15/562,804 · Granted Aug 23, 2022

Intensification of biocatalytic gas absorption

Inventors: Mausam Verma (Québec, CA); Louis Fradette (Québec, CA); Sylvie Fradette (Québec, CA); Sylvain Lefebvre (Québec, CA); Vincent Sylvestre-Laurence (Québec, CA)
Assignee: SAIPEM S.P.A.
B01D53/84B01D19/04B01D53/1475B01D53/62B01D53/77B01D53/78B01D53/96C12P3/00B01D2251/304B01D2251/306B01D2251/606B01D2252/20421B01D2252/20426B01D2252/20431B01D2252/20478B01D2252/20484B01D2252/20494B01D2252/602B01D2252/608B01D2255/804B01D2257/504Y02A50/20Y02C20/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,420,159
App. No.
15/562,804
Granted
Aug 23, 2022
Kind
B2
Abstract

Intensification techniques are described for enhancing biocatalytic CO 2 absorption operations, and may include the use of a rotating packed bed, a rotating disc reactor, a zig-zag reactor or other reactors that utilize process intensification. Carbonic anhydrase can be deployed in the high intensity reactor free in solution, immobilized with respect to particles that flow with the liquid, and/or immobilized to internals, such as packing, that are fixed within the high intensity reactor.

Claims (31)

1. A biocatalytic process for treating a CO 2 containing gas, comprising:

supplying CO 2 containing gas into a rotating packed bed (RPB) comprising a reaction chamber;

supplying an absorption solution into the RPB;

contacting the CO 2 containing gas and the absorption solution within the reaction chamber, in the presence of carbonic anhydrase, under fluid acceleration conditions of at least 50 m/s 2 to convert dissolved CO 2 into bicarbonate and hydrogen ions and to form a CO 2 depleted gas and an ion enriched solution free of bicarbonate precipitates, wherein the carbonic anhydrase is free in the absorption solution in that the carbonic anhydrase is not immobilized on or in particles flowing with the absorption solution and the carbonic anhydrase flows with the absorption solution; and

withdrawing the CO 2 depleted gas and an ion enriched solution from the RPB.

2. The biocatalytic process of claim 1 , comprising supplying the ion enriched solution to a regeneration unit to produce a regenerated liquid stream and a CO 2 gas stream.

3. The biocatalytic process of claim 2 , wherein all of the ion enriched solution is supplied directly to the regeneration unit.

4. The biocatalytic process of claim 3 , wherein the ion enriched solution passes through a heat exchanger prior to being introduced into the regeneration unit.

5. The biocatalytic process of claim 1 , wherein the absorption solution further comprises a defoamer comprising a silicon based compound and the defoamer is provided in a concentration of at least 50 mg/L.

6. The biocatalytic process of claim 5 , wherein the carbonic anhydrase is present in an enzyme concentration between about 0.1 g/L and about 2 g/L.

7. The biocatalytic process of claim 5 , wherein the carbonic anhydrase is present in an enzyme concentration between about 0.2 g/L and about 1.5 g/L.

8. The biocatalytic process of claim 5 , wherein the carbonic anhydrase is present in an enzyme concentration between about 0.5 g/L and about 1 g/L.

9. The biocatalytic process of claim 1 , wherein the absorption solution comprises a carbonate compound.

10. The biocatalytic process of claim 9 , wherein the carbonate compound comprises a monovalent metal ion.

11. The biocatalytic process of claim 10 , wherein the carbonate compound comprises sodium carbonate.

12. The biocatalytic process of claim 10 , wherein the carbonate compound comprises potassium carbonate.

13. The biocatalytic process claim 1 , wherein the contacting of the CO 2 containing gas and the absorption solution is performed in one pass through the reaction chamber.

14. The biocatalytic process of claim 1 , wherein packing material in the reaction chamber comprises metal foam.

15. The biocatalytic process of claim 1 , wherein packing material in the reaction chamber has between 80% and 95% porosity.

16. The biocatalytic process of claim 1 , wherein the rotating packed bed is operated to provide fluid acceleration of at least 335 m/s 2 .

17. The biocatalytic process of claim 1 , wherein the rotating packed bed has a radius of 0.1 m to 0.2 m and is operated with a rotational speed between 450 and 1200 rotations per minute.

18. The biocatalytic process of claim 1 , wherein the absorption solution further comprises a defoamer.

19. The biocatalytic process of claim 1 , wherein the RPB is operated at a liquid to gas (L/G) ratio that is between about 30 and about 300 on a w/w basis.

20. The biocatalytic process of claim 1 , further comprising providing heat to the RPB from low-grade heat via a heat transfer fluid.

21. A biocatalytic process for treating a CO 2 containing gas, comprising:

supplying CO 2 containing gas into a rotating packed bed (RPB) comprising a reaction chamber;

supplying an absorption solution into the RPB;

contacting the CO 2 containing gas and the absorption solution within the reaction chamber, in the presence of carbonic anhydrase, under fluid acceleration conditions of at least 50 m/s 2 to convert dissolved CO 2 into bicarbonate and hydrogen ions and to form a CO 2 depleted gas and an ion enriched solution free of bicarbonate precipitates,

wherein the carbonic anhydrase is free in the absorption solution in that the carbonic anhydrase is not immobilized on or in particles flowing with the absorption solution and the carbonic anhydrase flows with the absorption solution; and

withdrawing the CO 2 depleted gas and an ion enriched solution from the RPB, wherein the absorption solution comprises a defoamer.

22. The biocatalytic process of claim 21 , wherein the defoamer is present in the absorption solution at a concentration of 50 to 300 mg/L.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2020
From: CO2 SOLUTIONS INC.
To: SAIPEM S.P.A.
Reel/Frame 053701/0652 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2017
From: VERMA, MAUSAM; FRADETTE, LOUIS; FRADETTE, SYLVIE; LEFEBVRE, SYLVAIN; SYLVESTRE-LAURENCE, VINCENT
To: CO2 SOLUTIONS INC.
Reel/Frame 043730/0058 →
Priority Claims (1)
CA CA 2886708 · Mar 30, 2015 · national
Continuity (1)
Related Publication 20180280871A1 · Oct 4, 2018